Maclos Capital EBIT

Maclos Capital posts a EBIT of $-77K as of December 2018. That compares with $-43K in the prior-year period — down 79.7% year over year. That is below the Healthcare sector average of $22B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Maclos Capital's EBIT was $-43K. The latest reading is $-77K — a 79.7% year-over-year decrease (period ending December 2018). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a EBIT near $22B is typical. Maclos Capital's $-77K is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Maclos Capital's financial statement story. At $-77K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LMSMF's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $22B), and (3) consistency with growth and profitability. This page covers the first two; Maclos Capital's other metric pages and overview cover the third.